Autophagy in benign prostatic hyperplasia: insights and therapeutic potential

BMC Urol. 2024 Sep 12;24(1):198. doi: 10.1186/s12894-024-01585-7.

Abstract

Autophagy is a cellular homeostatic mechanism characterized by cyclic degradation. It plays an essential role in maintaining cellular quality and survival by eliminating dysfunctional cellular components. This process is pivotal in various pathophysiological processes. Benign prostatic hyperplasia (BPH) is a common urological disorder in middle-aged and elderly men. It frequently presents as lower urinary tract symptoms due to an increase in epithelial and stromal cells surrounding the prostatic urethra. The precise pathogenesis of BPH is complex. In recent years, research on autophagy in BPH has gained significant momentum, with accumulating evidence indicating its crucial role in the onset and progression of the disease. This review aims to outline the various roles of autophagy in BPH and elucidate potential therapeutic strategies targeting autophagy for managing BPH.

Keywords: Autophagy; BPH; Benign prostatic hyperplasia; Cell death pathways; Herbal therapy; Signaling pathways.

Publication types

  • Review

MeSH terms

  • Autophagy* / physiology
  • Humans
  • Male
  • Prostatic Hyperplasia* / therapy